So let's not forget the vision of this company(lat

So let's not forget the vision of this company(late 2018) prior Covid ....... turnkey acquisitions (revenue generating ops), cash/2.50pps agreements , MSO in 27 states, Nasdaq (high priority), and planned share dilution not to exceed approx 69M........... Now we are in 2021 , 112.5M shares, no revenue and looking at an NGIO IPO .......looks like a vaccine if successful the only way to move forward. I'm skeptical how this Management will spend any IPO funds .............. I can't imagine institutional support based on current results unless positive vaccine news ahead. Lawsuits , note conversions , toxic funding all unfortunate circumstances due to unrealistic expectations. Maybe a clarification of the 500M valuation can attract more interest to support a higher pps.